207 related articles for article (PubMed ID: 26067931)
1. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
[TBL] [Abstract][Full Text] [Related]
2. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.
Johns C; Seav SM; Dominick SA; Gorman JR; Li H; Natarajan L; Mao JJ; Irene Su H
Breast Cancer Res Treat; 2016 Apr; 156(3):415-426. PubMed ID: 27015968
[TBL] [Abstract][Full Text] [Related]
3. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.
L'Espérance S; Frenette S; Dionne A; Dionne JY;
Support Care Cancer; 2013 May; 21(5):1461-74. PubMed ID: 23435567
[TBL] [Abstract][Full Text] [Related]
7. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
13. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
15. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.
Bardia A; Novotny P; Sloan J; Barton D; Loprinzi C
Menopause; 2009; 16(3):477-83. PubMed ID: 19188850
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
19. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Sarkissian A; Neher JO; Singh R; St Anna L
J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
[TBL] [Abstract][Full Text] [Related]
20. Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
Hutton B; Yazdi F; Bordeleau L; Morgan S; Cameron C; Kanji S; Fergusson D; Tricco A; Straus S; Skidmore B; Hersi M; Pratt M; Mazzarello S; Brouwers M; Moher D; Clemons M
Syst Rev; 2015 Aug; 4():114. PubMed ID: 26307105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
